<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">36012536</PMID><DateCompleted><Year>2022</Year><Month>08</Month><Day>29</Day></DateCompleted><DateRevised><Year>2022</Year><Month>08</Month><Day>31</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>23</Volume><Issue>16</Issue><PubDate><Year>2022</Year><Month>Aug</Month><Day>17</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle><i>TMEM106B</i> Acts as a Modifier of Cognitive and Motor Functions in Amyotrophic Lateral Sclerosis.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">9276</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms23169276</ELocationID><Abstract><AbstractText>The transmembrane protein 106B (<i>TMEM106B</i>) gene is a susceptibility factor and disease modifier of frontotemporal dementia, but few studies have investigated its role in amyotrophic lateral sclerosis. The aim of this work was to assess the impact of the <i>TMEM106B</i> rs1990622 (A-major risk allele; G-minor allele) on phenotypic variability of 865 patients with amyotrophic lateral sclerosis. Demographic and clinical features were compared according to genotypes by additive, dominant, and recessive genetic models. Bulbar onset was overrepresented among carriers of the AA risk genotype, together with enhanced upper motor neuron involvement and poorer functional status in patients harboring at least one major risk allele (A). In a subset of 195 patients, we found that the homozygotes for the minor allele (GG) showed lower scores at the Edinburgh Cognitive and Behavioral Amyotrophic Lateral Sclerosis Screen, indicating a more severe cognitive impairment, mainly involving the amyotrophic lateral sclerosis-specific cognitive functions and memory. Moreover, lower motor neuron burden predominated among patients with at least one minor allele (G). Overall, we found that <i>TMEM106B</i> is a disease modifier of amyotrophic lateral sclerosis, whose phenotypic effects encompass both sites of onset and functional status (major risk allele), motor functions (both major risk and minor alleles), and cognition (minor allele).</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Manini</LastName><ForeName>Arianna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Neurology Residency Program, Universit&#xe0; degli Studi di Milano, 20122 Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology and Laboratory of Neuroscience, IRCCS Istituto Auxologico Italiano, 20149 Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ratti</LastName><ForeName>Antonia</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Neurology and Laboratory of Neuroscience, IRCCS Istituto Auxologico Italiano, 20149 Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Biotechnology and Molecular Medicine, Universit&#xe0; degli Studi di Milano, 20122 Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brusati</LastName><ForeName>Alberto</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Neurology and Laboratory of Neuroscience, IRCCS Istituto Auxologico Italiano, 20149 Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Dipartimento di Scienze del Sistema Nervoso e del Comportamento, Universit&#xe0; degli Studi di Pavia, 27100 Pavia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maranzano</LastName><ForeName>Alessio</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Neurology Residency Program, Universit&#xe0; degli Studi di Milano, 20122 Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology and Laboratory of Neuroscience, IRCCS Istituto Auxologico Italiano, 20149 Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fogh</LastName><ForeName>Isabella</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Basic and Clinical Neuroscience, Maurice Wohl Clinical Neuroscience Institute, King's College London, London SE1 8WA, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peverelli</LastName><ForeName>Silvia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Neurology and Laboratory of Neuroscience, IRCCS Istituto Auxologico Italiano, 20149 Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Messina</LastName><ForeName>Stefano</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Neurology and Laboratory of Neuroscience, IRCCS Istituto Auxologico Italiano, 20149 Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gentilini</LastName><ForeName>Davide</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Dipartimento di Scienze del Sistema Nervoso e del Comportamento, Universit&#xe0; degli Studi di Pavia, 27100 Pavia, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Bioinformatics and Statistical Genomics Unit, IRCCS Istituto Auxologico Italiano, 20090 Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Verde</LastName><ForeName>Federico</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Neurology and Laboratory of Neuroscience, IRCCS Istituto Auxologico Italiano, 20149 Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pathophysiology and Transplantation, 'Dino Ferrari' Center, Universit&#xe0; degli Studi di Milano, 20122 Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Poletti</LastName><ForeName>Barbara</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Neurology and Laboratory of Neuroscience, IRCCS Istituto Auxologico Italiano, 20149 Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morelli</LastName><ForeName>Claudia</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0003-4027-958X</Identifier><AffiliationInfo><Affiliation>Department of Neurology and Laboratory of Neuroscience, IRCCS Istituto Auxologico Italiano, 20149 Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Silani</LastName><ForeName>Vincenzo</ForeName><Initials>V</Initials><Identifier Source="ORCID">0000-0002-7698-3854</Identifier><AffiliationInfo><Affiliation>Department of Neurology and Laboratory of Neuroscience, IRCCS Istituto Auxologico Italiano, 20149 Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pathophysiology and Transplantation, 'Dino Ferrari' Center, Universit&#xe0; degli Studi di Milano, 20122 Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ticozzi</LastName><ForeName>Nicola</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0001-5963-7426</Identifier><AffiliationInfo><Affiliation>Department of Neurology and Laboratory of Neuroscience, IRCCS Istituto Auxologico Italiano, 20149 Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pathophysiology and Transplantation, 'Dino Ferrari' Center, Universit&#xe0; degli Studi di Milano, 20122 Milan, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>Ricerca Corrente to IRCCS Istituto Auxologico Italiano (project DAMARE)</GrantID><Agency>Ministero della Salute</Agency><Country/></Grant><Grant><GrantID>GR-2016-02364373</GrantID><Agency>Ministero della Salute</Agency><Country/></Grant><Grant><GrantID>Azygos 2.0</GrantID><Agency>Fondazione Italiana di Ricerca per la Sclerosi Laterale Amiotrofica</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>08</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008565">Membrane Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D009419">Nerve Tissue Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C556915">TMEM106B protein, human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003071" MajorTopicYN="N">Cognition</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057180" MajorTopicYN="Y">Frontotemporal Dementia</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008565" MajorTopicYN="Y">Membrane Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009419" MajorTopicYN="Y">Nerve Tissue Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">TMEM106B</Keyword><Keyword MajorTopicYN="N">alleles</Keyword><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">cognition</Keyword><Keyword MajorTopicYN="N">frontotemporal lobar degeneration</Keyword><Keyword MajorTopicYN="N">motor neurons</Keyword></KeywordList><CoiStatement>V. Silani received compensation for consulting services and/or speaking activities from AveXis, Cytokinetics, Italfarmaco, Liquidweb Srl, and Novartis Pharma AG. He is on the Editorial Board of Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, European Neurology, American Journal of Neurodegenerative Diseases, and Frontiers in Neurology. N. Ticozzi received compensation for consulting services from Amylyx Pharmaceuticals and Zambon Biotech SA. He is Associate Editor for Frontiers in Aging Neuroscience.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>7</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>8</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>8</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>8</Month><Day>26</Day><Hour>1</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>8</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>8</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36012536</ArticleId><ArticleId IdType="pmc">PMC9408885</ArticleId><ArticleId IdType="doi">10.3390/ijms23169276</ArticleId><ArticleId IdType="pii">ijms23169276</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Vieira R.T. Epidemiology of Early-Onset Dementia: A Review of the Literature. Clin. Pract. Epidemiol. Ment. Health. 2013;9:88&#x2013;95. doi: 10.2174/1745017901309010088.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1745017901309010088</ArticleId><ArticleId IdType="pmc">PMC3715758</ArticleId><ArticleId IdType="pubmed">23878613</ArticleId></ArticleIdList></Reference><Reference><Citation>Bang J., Spina S., Miller B.L. Frontotemporal Dementia. Lancet. 2015;386:1672&#x2013;1682. doi: 10.1016/S0140-6736(15)00461-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(15)00461-4</ArticleId><ArticleId IdType="pmc">PMC5970949</ArticleId><ArticleId IdType="pubmed">26595641</ArticleId></ArticleIdList></Reference><Reference><Citation>Josephs K.A., Holton J.L., Rossor M.N., Godbolt A.K., Ozawa T., Strand K., Khan N., Al-Sarraj S., Revesz T. Frontotemporal Lobar Degeneration and Ubiquitin Immunohistochemistry. Neuropathol. Appl. Neurobiol. 2004;30:369&#x2013;373. doi: 10.1111/j.1365-2990.2003.00545.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2990.2003.00545.x</ArticleId><ArticleId IdType="pubmed">15305982</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson J.K., Diehl J., Mendez M.F., Neuhaus J., Shapira J.S., Forman M., Chute D.J., Roberson E.D., Pace-Savitsky C., Neumann M., et al. Frontotemporal Lobar Degeneration. Arch. Neurol. 2005;62:925&#x2013;930. doi: 10.1001/archneur.62.6.925.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneur.62.6.925</ArticleId><ArticleId IdType="pubmed">15956163</ArticleId></ArticleIdList></Reference><Reference><Citation>Arai T., Hasegawa M., Akiyama H., Ikeda K., Nonaka T., Mori H., Mann D., Tsuchiya K., Yoshida M., Hashizume Y., et al. TDP-43 Is a Component of Ubiquitin-Positive Tau-Negative Inclusions in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis. Biochem. Biophys. Res. Commun. 2006;351:602&#x2013;611. doi: 10.1016/j.bbrc.2006.10.093.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2006.10.093</ArticleId><ArticleId IdType="pubmed">17084815</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M., Rademakers R., Roeber S., Baker M., Kretzschmar H.A., Mackenzie I.R.A. A New Subtype of Frontotemporal Lobar Degeneration with FUS Pathology. Brain. 2009;132:2922&#x2013;2931. doi: 10.1093/brain/awp214.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awp214</ArticleId><ArticleId IdType="pmc">PMC2768659</ArticleId><ArticleId IdType="pubmed">19674978</ArticleId></ArticleIdList></Reference><Reference><Citation>Hutton M., Lendon C.L., Rizzu P., Baker M., Froelich S., Houlden H., Pickering-Brown S., Chakraverty S., Isaacs A., Grover A., et al. Association of Missense and 5&#x2019;-Splice-Site Mutations in Tau with the Inherited Dementia FTDP-17. Nature. 1998;393:702&#x2013;705. doi: 10.1038/31508.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/31508</ArticleId><ArticleId IdType="pubmed">9641683</ArticleId></ArticleIdList></Reference><Reference><Citation>DeJesus-Hernandez M., Mackenzie I.R., Boeve B.F., Boxer A.L., Baker M., Rutherford N.J., Nicholson A.M., Finch N.A., Flynn H., Adamson J., et al. Expanded GGGGCC Hexanucleotide Repeat in Noncoding Region of C9ORF72 Causes Chromosome 9p-Linked FTD and ALS. Neuron. 2011;72:245&#x2013;256. doi: 10.1016/j.neuron.2011.09.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2011.09.011</ArticleId><ArticleId IdType="pmc">PMC3202986</ArticleId><ArticleId IdType="pubmed">21944778</ArticleId></ArticleIdList></Reference><Reference><Citation>Baker M., Mackenzie I.R., Pickering-Brown S.M., Gass J., Rademakers R., Lindholm C., Snowden J., Adamson J., Sadovnick A.D., Rollinson S., et al. Mutations in Progranulin Cause Tau-Negative Frontotemporal Dementia Linked to Chromosome 17. Nature. 2006;442:916&#x2013;919. doi: 10.1038/nature05016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature05016</ArticleId><ArticleId IdType="pubmed">16862116</ArticleId></ArticleIdList></Reference><Reference><Citation>Cruts M., Gijselinck I., van der Zee J., Engelborghs S., Wils H., Pirici D., Rademakers R., Vandenberghe R., Dermaut B., Martin J.-J., et al. Null Mutations in Progranulin Cause Ubiquitin-Positive Frontotemporal Dementia Linked to Chromosome 17q21. Nature. 2006;442:920&#x2013;924. doi: 10.1038/nature05017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature05017</ArticleId><ArticleId IdType="pubmed">16862115</ArticleId></ArticleIdList></Reference><Reference><Citation>Snowden J.S., Pickering-Brown S.M., Mackenzie I.R., Richardson A.M.T., Varma A., Neary D., Mann D.M.A. Progranulin Gene Mutations Associated with Frontotemporal Dementia and Progressive Non-Fluent Aphasia. Brain. 2006;129:3091&#x2013;3102. doi: 10.1093/brain/awl267.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awl267</ArticleId><ArticleId IdType="pubmed">17003069</ArticleId></ArticleIdList></Reference><Reference><Citation>Freischmidt A., Wieland T., Richter B., Ruf W., Schaeffer V., M&#xfc;ller K., Marroquin N., Nordin F., H&#xfc;bers A., Weydt P., et al. Haploinsufficiency of TBK1 Causes Familial ALS and Fronto-Temporal Dementia. Nat. Neurosci. 2015;18:631&#x2013;636. doi: 10.1038/nn.4000.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.4000</ArticleId><ArticleId IdType="pubmed">25803835</ArticleId></ArticleIdList></Reference><Reference><Citation>Watts G.D.J., Wymer J., Kovach M.J., Mehta S.G., Mumm S., Darvish D., Pestronk A., Whyte M.P., Kimonis V.E. Inclusion Body Myopathy Associated with Paget Disease of Bone and Frontotemporal Dementia Is Caused by Mutant Valosin-Containing Protein. Nat. Genet. 2004;36:377&#x2013;381. doi: 10.1038/ng1332.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng1332</ArticleId><ArticleId IdType="pubmed">15034582</ArticleId></ArticleIdList></Reference><Reference><Citation>Skibinski G., Parkinson N.J., Brown J.M., Chakrabarti L., Lloyd S.L., Hummerich H., Nielsen J.E., Hodges J.R., Spillantini M.G., Thusgaard T., et al. Mutations in the Endosomal ESCRTIII-Complex Subunit CHMP2B in Frontotemporal Dementia. Nat. Genet. 2005;37:806&#x2013;808. doi: 10.1038/ng1609.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng1609</ArticleId><ArticleId IdType="pubmed">16041373</ArticleId></ArticleIdList></Reference><Reference><Citation>Renton A.E., Chi&#xf2; A., Traynor B.J. State of Play in Amyotrophic Lateral Sclerosis Genetics. Nat. Neurosci. 2014;17:17&#x2013;23. doi: 10.1038/nn.3584.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.3584</ArticleId><ArticleId IdType="pmc">PMC4544832</ArticleId><ArticleId IdType="pubmed">24369373</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Deerlin V.M., Sleiman P.M.A., Martinez-Lage M., Chen-Plotkin A., Wang L.-S., Graff-Radford N.R., Dickson D.W., Rademakers R., Boeve B.F., Grossman M., et al. Common Variants at 7p21 Are Associated with Frontotemporal Lobar Degeneration with TDP-43 Inclusions. Nat. Genet. 2010;42:234&#x2013;239. doi: 10.1038/ng.536.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.536</ArticleId><ArticleId IdType="pmc">PMC2828525</ArticleId><ArticleId IdType="pubmed">20154673</ArticleId></ArticleIdList></Reference><Reference><Citation>Brady O.A., Zheng Y., Murphy K., Huang M., Hu F. The Frontotemporal Lobar Degeneration Risk Factor, TMEM106B, Regulates Lysosomal Morphology and Function. Hum. Mol. Genet. 2013;22:685&#x2013;695. doi: 10.1093/hmg/dds475.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/dds475</ArticleId><ArticleId IdType="pmc">PMC3554197</ArticleId><ArticleId IdType="pubmed">23136129</ArticleId></ArticleIdList></Reference><Reference><Citation>Busch J.I., Martinez-Lage M., Ashbridge E., Grossman M., Van Deerlin V.M., Hu F., Lee V.M., Trojanowski J.Q., Chen-Plotkin A.S. Expression of TMEM106B, the Frontotemporal Lobar Degeneration-Associated Protein, in Normal and Diseased Human Brain. Acta Neuropathol. Commun. 2013;1:36. doi: 10.1186/2051-5960-1-36.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/2051-5960-1-36</ArticleId><ArticleId IdType="pmc">PMC3893524</ArticleId><ArticleId IdType="pubmed">24252750</ArticleId></ArticleIdList></Reference><Reference><Citation>Van der Zee J., Van Langenhove T., Kleinberger G., Sleegers K., Engelborghs S., Vandenberghe R., Santens P., Van den Broeck M., Joris G., Brys J., et al. TMEM106B Is Associated with Frontotemporal Lobar Degeneration in a Clinically Diagnosed Patient Cohort. Brain. 2011;134:808&#x2013;815. doi: 10.1093/brain/awr007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awr007</ArticleId><ArticleId IdType="pmc">PMC3044834</ArticleId><ArticleId IdType="pubmed">21354975</ArticleId></ArticleIdList></Reference><Reference><Citation>Finch N., Carrasquillo M.M., Baker M., Rutherford N.J., Coppola G., DeJesus-Hernandez M., Crook R., Hunter T., Ghidoni R., Benussi L., et al. TMEM106B Regulates Progranulin Levels and the Penetrance of FTLD in GRN Mutation Carriers. Neurology. 2011;76:467&#x2013;474. doi: 10.1212/WNL.0b013e31820a0e3b.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e31820a0e3b</ArticleId><ArticleId IdType="pmc">PMC3034409</ArticleId><ArticleId IdType="pubmed">21178100</ArticleId></ArticleIdList></Reference><Reference><Citation>Hern&#xe1;ndez I., Rosende-Roca M., Alegret M., Maule&#xf3;n A., Espinosa A., Vargas L., Sotolongo-Grau O., T&#xe1;rraga L., Boada M., Ruiz A. Association of TMEM106B Rs1990622 Marker and Frontotemporal Dementia: Evidence for a Recessive Effect and Meta-Analysis. J. Alzheimer&#x2019;s Dis. 2014;43:325&#x2013;334. doi: 10.3233/JAD-132432.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-132432</ArticleId><ArticleId IdType="pubmed">25096617</ArticleId></ArticleIdList></Reference><Reference><Citation>van Blitterswijk M., Mullen B., Nicholson A.M., Bieniek K.F., Heckman M.G., Baker M.C., DeJesus-Hernandez M., Finch N.A., Brown P.H., Murray M.E., et al. TMEM106B Protects C9ORF72 Expansion Carriers against Frontotemporal Dementia. Acta Neuropathol. 2014;127:397&#x2013;406. doi: 10.1007/s00401-013-1240-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-013-1240-4</ArticleId><ArticleId IdType="pmc">PMC3944829</ArticleId><ArticleId IdType="pubmed">24385136</ArticleId></ArticleIdList></Reference><Reference><Citation>Pottier C., Zhou X., Perkerson R.B., Baker M., Jenkins G.D., Serie D.J., Ghidoni R., Benussi L., Binetti G., L&#xf3;pez de Munain A., et al. Potential Genetic Modifiers of Disease Risk and Age at Onset in Patients with Frontotemporal Lobar Degeneration and GRN Mutations: A Genome-Wide Association Study. Lancet Neurol. 2018;17:548&#x2013;558. doi: 10.1016/S1474-4422(18)30126-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(18)30126-1</ArticleId><ArticleId IdType="pmc">PMC6237181</ArticleId><ArticleId IdType="pubmed">29724592</ArticleId></ArticleIdList></Reference><Reference><Citation>Lattante S., Le Ber I., Galimberti D., Serpente M., Rivaud-P&#xe9;choux S., Camuzat A., Clot F., Fenoglio C., Scarpini E., Brice A., et al. Defining the Association of TMEM106B Variants among Frontotemporal Lobar Degeneration Patients with GRN Mutations and C9orf72 Repeat Expansions. Neurobiol. Aging. 2014;35:2658.e1&#x2013;2658.e5. doi: 10.1016/j.neurobiolaging.2014.06.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2014.06.023</ArticleId><ArticleId IdType="pubmed">25085782</ArticleId></ArticleIdList></Reference><Reference><Citation>Cruchaga C., Graff C., Chiang H.-H., Wang J., Hinrichs A.L., Spiegel N., Bertelsen S., Mayo K., Norton J.B., Morris J.C., et al. Association of TMEM106B Gene Polymorphism With Age at Onset in Granulin Mutation Carriers and Plasma Granulin Protein Levels. Arch. Neurol. 2011;68:581&#x2013;586. doi: 10.1001/archneurol.2010.350.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneurol.2010.350</ArticleId><ArticleId IdType="pmc">PMC3090529</ArticleId><ArticleId IdType="pubmed">21220649</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicholson A.M., Finch N.A., Wojtas A., Baker M.C., Perkerson R.B., Castanedes-Casey M., Rousseau L., Benussi L., Binetti G., Ghidoni R., et al. TMEM106B p.T185S Regulates TMEM106B Protein Levels: Implications for Frontotemporal Dementia. J. Neurochem. 2013;126:781&#x2013;791. doi: 10.1111/jnc.12329.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnc.12329</ArticleId><ArticleId IdType="pmc">PMC3766501</ArticleId><ArticleId IdType="pubmed">23742080</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwenk B.M., Lang C.M., Hogl S., Tahirovic S., Orozco D., Rentzsch K., Lichtenthaler S.F., Hoogenraad C.C., Capell A., Haass C., et al. The FTLD Risk Factor TMEM106B and MAP6 Control Dendritic Trafficking of Lysosomes. EMBO J. 2013;33:450&#x2013;467. doi: 10.1002/embj.201385857.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/embj.201385857</ArticleId><ArticleId IdType="pmc">PMC3989627</ArticleId><ArticleId IdType="pubmed">24357581</ArticleId></ArticleIdList></Reference><Reference><Citation>Busch J.I., Unger T.L., Jain N., Skrinak R.T., Charan R.A., Chen-Plotkin A.S. Increased Expression of the Frontotemporal Dementia Risk Factor TMEM106B Causes C9orf72-Dependent Alterations in Lysosomes. Hum. Mol. Genet. 2016;25:2681&#x2013;2697. doi: 10.1093/hmg/ddw127.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddw127</ArticleId><ArticleId IdType="pmc">PMC5181637</ArticleId><ArticleId IdType="pubmed">27126638</ArticleId></ArticleIdList></Reference><Reference><Citation>Gallagher M.D., Suh E., Grossman M., Elman L., McCluskey L., Van Swieten J.C., Al-Sarraj S., Neumann M., Gelpi E., Ghetti B., et al. TMEM106B Is a Genetic Modifier of Frontotemporal Lobar Degeneration with C9orf72 Hexanucleotide Repeat Expansions. Acta Neuropathol. 2014;127:407&#x2013;418. doi: 10.1007/s00401-013-1239-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-013-1239-x</ArticleId><ArticleId IdType="pmc">PMC4003885</ArticleId><ArticleId IdType="pubmed">24442578</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu T., Chen Y., Ou R., Wei Q., Cao B., Zhao B., Wu Y., Song W., Chen X., Shang H.-F. Association Analysis of Polymorphisms in VMAT2 and TMEM106B Genes for Parkinson&#x2019;s Disease, Amyotrophic Lateral Sclerosis and Multiple System Atrophy. J. Neurol. Sci. 2017;377:65&#x2013;71. doi: 10.1016/j.jns.2017.03.028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2017.03.028</ArticleId><ArticleId IdType="pubmed">28477711</ArticleId></ArticleIdList></Reference><Reference><Citation>Vass R., Ashbridge E., Geser F., Hu W.T., Grossman M., Clay-Falcone D., Elman L., McCluskey L., Lee V.M.Y., Van Deerlin V.M., et al. Risk Genotypes at TMEM106B Are Associated with Cognitive Impairment in Amyotrophic Lateral Sclerosis. Acta Neuropathol. 2011;121:373&#x2013;380. doi: 10.1007/s00401-010-0782-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-010-0782-y</ArticleId><ArticleId IdType="pmc">PMC3095217</ArticleId><ArticleId IdType="pubmed">21104415</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Blitterswijk M., Mullen B., Wojtas A., Heckman M.G., Diehl N.N., Baker M.C., DeJesus-Hernandez M., Brown P.H., Murray M.E., Hsiung G.-Y.R., et al. Genetic Modifiers in Carriers of Repeat Expansions in the C9ORF72 Gene. Mol. Neurodegener. 2014;9:38. doi: 10.1186/1750-1326-9-38.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1750-1326-9-38</ArticleId><ArticleId IdType="pmc">PMC4190282</ArticleId><ArticleId IdType="pubmed">25239657</ArticleId></ArticleIdList></Reference><Reference><Citation>Tropea T.F., Mak J., Guo M.H., Xie S.X., Suh E., Rick J., Siderowf A., Weintraub D., Grossman M., Irwin D., et al. TMEM106B Effect on Cognition in Parkinson Disease and Frontotemporal Dementia. Ann. Neurol. 2019;85:801&#x2013;811. doi: 10.1002/ana.25486.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.25486</ArticleId><ArticleId IdType="pmc">PMC6953172</ArticleId><ArticleId IdType="pubmed">30973966</ArticleId></ArticleIdList></Reference><Reference><Citation>Adams H.H.H., Verhaaren B.F.J., Vrooman H.A., Uitterlinden A.G., Hofman A., van Duijn C.M., van der Lugt A., Niessen W.J., Vernooij M.W., Ikram M.A. TMEM106B Influences Volume of Left-Sided Temporal Lobe and Interhemispheric Structures in the General Population. Biol. Psychiatry. 2014;76:503&#x2013;508. doi: 10.1016/j.biopsych.2014.03.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopsych.2014.03.006</ArticleId><ArticleId IdType="pubmed">24731779</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamauchi H. Comparison of the Pattern of Atrophy of the Corpus Callosum in Frontotemporal Dementia, Progressive Supranuclear Palsy, and Alzheimer&#x2019;s Disease. J. Neurol. Neurosurg. Psychiatry. 2000;69:623&#x2013;629. doi: 10.1136/jnnp.69.5.623.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.69.5.623</ArticleId><ArticleId IdType="pmc">PMC1763404</ArticleId><ArticleId IdType="pubmed">11032614</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim E.J., Rabinovici G.D., Seeley W.W., Halabi C., Shu H., Weiner M.W., DeArmond S.J., Trojanowski J.Q., Gorno-Tempini M.L., Miller B.L., et al. Patterns of MRI Atrophy in Tau Positive and Ubiquitin Positive Frontotemporal Lobar Degeneration. J. Neurol. Neurosurg. Psychiatry. 2007;78:1375&#x2013;1378. doi: 10.1136/jnnp.2006.114231.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.2006.114231</ArticleId><ArticleId IdType="pmc">PMC2095621</ArticleId><ArticleId IdType="pubmed">17615169</ArticleId></ArticleIdList></Reference><Reference><Citation>Borroni B., Alberici A., Cercignani M., Premi E., Serra L., Cerini C., Cosseddu M., Pettenati C., Turla M., Archetti S., et al. Granulin Mutation Drives Brain Damage and Reorganization from Preclinical to Symptomatic FTLD. Neurobiol. Aging. 2012;33:2506&#x2013;2520. doi: 10.1016/j.neurobiolaging.2011.10.031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2011.10.031</ArticleId><ArticleId IdType="pubmed">22130207</ArticleId></ArticleIdList></Reference><Reference><Citation>Filippi M., Agosta F., Scola E., Canu E., Magnani G., Marcone A., Valsasina P., Caso F., Copetti M., Comi G., et al. Functional Network Connectivity in the Behavioral Variant of Frontotemporal Dementia. Cortex. 2013;49:2389&#x2013;2401. doi: 10.1016/j.cortex.2012.09.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cortex.2012.09.017</ArticleId><ArticleId IdType="pubmed">23164495</ArticleId></ArticleIdList></Reference><Reference><Citation>Premi E., Formenti A., Gazzina S., Archetti S., Gasparotti R., Padovani A., Borroni B. Effect of TMEM106B Polymorphism on Functional Network Connectivity in Asymptomatic GRN Mutation Carriers. JAMA Neurol. 2014;71:216. doi: 10.1001/jamaneurol.2013.4835.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2013.4835</ArticleId><ArticleId IdType="pubmed">24343233</ArticleId></ArticleIdList></Reference><Reference><Citation>Rutherford N.J., Carrasquillo M.M., Li M., Bisceglio G., Menke J., Josephs K.A., Parisi J.E., Petersen R.C., Graff-Radford N.R., Younkin S.G., et al. TMEM106B Risk Variant Is Implicated in the Pathologic Presentation of Alzheimer Disease. Neurology. 2012;79:717&#x2013;718. doi: 10.1212/WNL.0b013e318264e3ac.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e318264e3ac</ArticleId><ArticleId IdType="pmc">PMC3467659</ArticleId><ArticleId IdType="pubmed">22855871</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu L., De Jager P.L., Yang J., Trojanowski J.Q., Bennett D.A., Schneider J.A. The TMEM106B Locus and TDP-43 Pathology in Older Persons without FTLD. Neurology. 2015;84:927&#x2013;934. doi: 10.1212/WNL.0000000000001313.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000001313</ArticleId><ArticleId IdType="pmc">PMC4351662</ArticleId><ArticleId IdType="pubmed">25653292</ArticleId></ArticleIdList></Reference><Reference><Citation>Murray M.E., Cannon A., Graff-Radford N.R., Liesinger A.M., Rutherford N.J., Ross O.A., Duara R., Carrasquillo M.M., Rademakers R., Dickson D.W. Differential Clinicopathologic and Genetic Features of Late-Onset Amnestic Dementias. Acta Neuropathol. 2014;128:411&#x2013;421. doi: 10.1007/s00401-014-1302-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-014-1302-2</ArticleId><ArticleId IdType="pmc">PMC4412022</ArticleId><ArticleId IdType="pubmed">24899141</ArticleId></ArticleIdList></Reference><Reference><Citation>Nelson P.T., Wang W.-X., Partch A.B., Monsell S.E., Valladares O., Ellingson S.R., Wilfred B.R., Naj A.C., Wang L.-S., Kukull W.A., et al. Reassessment of Risk Genotypes (GRN, TMEM106B, and ABCC9 Variants) Associated With Hippocampal Sclerosis of Aging Pathology. J. Neuropathol. Exp. Neurol. 2015;74:75&#x2013;84. doi: 10.1097/NEN.0000000000000151.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/NEN.0000000000000151</ArticleId><ArticleId IdType="pmc">PMC4270894</ArticleId><ArticleId IdType="pubmed">25470345</ArticleId></ArticleIdList></Reference><Reference><Citation>Aoki N., Murray M.E., Ogaki K., Fujioka S., Rutherford N.J., Rademakers R., Ross O.A., Dickson D.W. Hippocampal Sclerosis in Lewy Body Disease Is a TDP-43 Proteinopathy Similar to FTLD-TDP Type A. Acta Neuropathol. 2015;129:53&#x2013;64. doi: 10.1007/s00401-014-1358-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-014-1358-z</ArticleId><ArticleId IdType="pmc">PMC4282950</ArticleId><ArticleId IdType="pubmed">25367383</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu R.-C., Wang H., Tan M.-S., Yu J.-T., Tan L. TMEM106B and APOE Polymorphisms Interact to Confer Risk for Late-Onset Alzheimer&#x2019;s Disease in Han Chinese. J. Neural Transm. 2014;121:283&#x2013;287. doi: 10.1007/s00702-013-1106-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00702-013-1106-x</ArticleId><ArticleId IdType="pubmed">24166182</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu Y., Sun J., Zhang Y., Zhang H., Gao S., Wang T., Han Z., Wang L., Sun B., Liu G. Rs1990622 Variant Associates with Alzheimer&#x2019;s Disease and Regulates TMEM106B Expression in Human Brain Tissues. BMC Med. 2021;19:11. doi: 10.1186/s12916-020-01883-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-020-01883-5</ArticleId><ArticleId IdType="pmc">PMC7814705</ArticleId><ArticleId IdType="pubmed">33461566</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldstein L., Atkins L., Leigh P. Correlates of Quality of Life in People with Motor Neuron Disease (MND) Amyotroph. Lateral Scler. Other Mot. Neuron Disord. 2002;3:123&#x2013;129. doi: 10.1080/146608202760834120.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/146608202760834120</ArticleId><ArticleId IdType="pubmed">12495573</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitsumoto H., Bene M. Del Improving the Quality of Life for People with ALS: The Challenge Ahead. Amyotroph. Lateral Scler. Other Mot. Neuron Disord. 2000;1:329&#x2013;336. doi: 10.1080/146608200300079464.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/146608200300079464</ArticleId><ArticleId IdType="pubmed">11464851</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi&#xf2; A., Logroscino G., Hardiman O., Swingler R., Mitchell D., Beghi E., Traynor B.G., On Behalf of the Eurals Consortium Prognostic Factors in ALS: A Critical Review. Amyotroph. Lateral Scler. 2009;10:310&#x2013;323. doi: 10.3109/17482960802566824.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482960802566824</ArticleId><ArticleId IdType="pmc">PMC3515205</ArticleId><ArticleId IdType="pubmed">19922118</ArticleId></ArticleIdList></Reference><Reference><Citation>Poletti B., Solca F., Carelli L., Madotto F., Lafronza A., Faini A., Monti A., Zago S., Calini D., Tiloca C., et al. The Validation of the Italian Edinburgh Cognitive and Behavioural ALS Screen (ECAS) Amyotroph. Lateral Scler. Front. Degener. 2016;17:489&#x2013;498. doi: 10.1080/21678421.2016.1183679.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2016.1183679</ArticleId><ArticleId IdType="pubmed">27219526</ArticleId></ArticleIdList></Reference><Reference><Citation>Montuschi A., Iazzolino B., Calvo A., Moglia C., Lopiano L., Restagno G., Brunetti M., Ossola I., Lo Presti A., Cammarosano S., et al. Cognitive Correlates in Amyotrophic Lateral Sclerosis: A Population-Based Study in Italy. J. Neurol. Neurosurg. Psychiatry. 2015;86:168&#x2013;173. doi: 10.1136/jnnp-2013-307223.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2013-307223</ArticleId><ArticleId IdType="pubmed">24769471</ArticleId></ArticleIdList></Reference><Reference><Citation>Strutt A.M., Palcic J., Wager J.G., Titus C., MacAdam C., Brown J., Scott B.M., Harati Y., Schulz P.E., York M.K. Cognition, Behavior, and Respiratory Function in Amyotrophic Lateral Sclerosis. ISRN Neurol. 2012;2012:912123. doi: 10.5402/2012/912123.</Citation><ArticleIdList><ArticleId IdType="doi">10.5402/2012/912123</ArticleId><ArticleId IdType="pmc">PMC3407622</ArticleId><ArticleId IdType="pubmed">22852095</ArticleId></ArticleIdList></Reference><Reference><Citation>Beeldman E., Raaphorst J., Klein Twennaar M., de Visser M., Schmand B.A., de Haan R.J. The Cognitive Profile of ALS: A Systematic Review and Meta-Analysis Update. J. Neurol. Neurosurg. Psychiatry. 2016;87:611&#x2013;619. doi: 10.1136/jnnp-2015-310734.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2015-310734</ArticleId><ArticleId IdType="pubmed">26283685</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks B.R., Miller R.G., Swash M., Munsat T.L. El Escorial Revisited: Revised Criteria for the Diagnosis of Amyotrophic Lateral Sclerosis. Amyotroph. Lateral Scler. Other Mot. Neuron Disord. 2000;1:293&#x2013;299. doi: 10.1080/146608200300079536.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/146608200300079536</ArticleId><ArticleId IdType="pubmed">11464847</ArticleId></ArticleIdList></Reference><Reference><Citation>Cedarbaum J.M., Stambler N., Malta E., Fuller C., Hilt D., Thurmond B., Nakanishi A. The ALSFRS-R: A Revised ALS Functional Rating Scale That Incorporates Assessments of Respiratory Function. J. Neurol. Sci. 1999;169:13&#x2013;21. doi: 10.1016/S0022-510X(99)00210-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-510X(99)00210-5</ArticleId><ArticleId IdType="pubmed">10540002</ArticleId></ArticleIdList></Reference><Reference><Citation>Quinn C., Edmundson C., Dahodwala N., Elman L. Reliable and Efficient Scale to Assess Upper Motor Neuron Disease Burden in Amyotrophic Lateral Sclerosis. Muscle Nerve. 2020;61:508&#x2013;511. doi: 10.1002/mus.26764.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.26764</ArticleId><ArticleId IdType="pubmed">31743477</ArticleId></ArticleIdList></Reference><Reference><Citation>Strong M.J., Abrahams S., Goldstein L.H., Woolley S., Mclaughlin P., Snowden J., Mioshi E., Roberts-South A., Benatar M., Hortob&#xe1;Gyi T., et al. Amyotrophic Lateral Sclerosis-Frontotemporal Spectrum Disorder (ALS-FTSD): Revised Diagnostic Criteria. Amyotroph. Lateral Scler. Front. Degener. 2017;18:153&#x2013;174. doi: 10.1080/21678421.2016.1267768.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2016.1267768</ArticleId><ArticleId IdType="pmc">PMC7409990</ArticleId><ArticleId IdType="pubmed">28054827</ArticleId></ArticleIdList></Reference><Reference><Citation>Alberici A., Geroldi C., Cotelli M., Adorni A., Calabria M., Rossi G., Borroni B., Padovani A., Zanetti O., Kertesz A. The Frontal Behavioural Inventory (Italian Version) Differentiates Frontotemporal Lobar Degeneration Variants from Alzheimer&#x2019;s Disease. Neurol. Sci. 2007;28:80&#x2013;86. doi: 10.1007/s10072-007-0791-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10072-007-0791-3</ArticleId><ArticleId IdType="pubmed">17464470</ArticleId></ArticleIdList></Reference><Reference><Citation>Rascovsky K., Hodges J.R., Knopman D., Mendez M.F., Kramer J.H., Neuhaus J., van Swieten J.C., Seelaar H., Dopper E.G.P., Onyike C.U., et al. Sensitivity of Revised Diagnostic Criteria for the Behavioural Variant of Frontotemporal Dementia. Brain. 2011;134:2456&#x2013;2477. doi: 10.1093/brain/awr179.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awr179</ArticleId><ArticleId IdType="pmc">PMC3170532</ArticleId><ArticleId IdType="pubmed">21810890</ArticleId></ArticleIdList></Reference><Reference><Citation>Gorno-Tempini M.L., Hillis A.E., Weintraub S., Kertesz A., Mendez M., Cappa S.F., Ogar J.M., Rohrer J.D., Black S., Boeve B.F., et al. Classification of Primary Progressive Aphasia and Its Variants. Neurology. 2011;76:1006&#x2013;1014. doi: 10.1212/WNL.0b013e31821103e6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e31821103e6</ArticleId><ArticleId IdType="pmc">PMC3059138</ArticleId><ArticleId IdType="pubmed">21325651</ArticleId></ArticleIdList></Reference><Reference><Citation>Govaarts R., Beeldman E., Kampelmacher M.J., van Tol M.-J., van den Berg L.H., van der Kooi A.J., Wijkstra P.J., Zijnen-Suyker M., Cobben N.A.M., Schmand B.A., et al. The Frontotemporal Syndrome of ALS Is Associated with Poor Survival. J. Neurol. 2016;263:2476&#x2013;2483. doi: 10.1007/s00415-016-8290-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-016-8290-1</ArticleId><ArticleId IdType="pmc">PMC5110703</ArticleId><ArticleId IdType="pubmed">27671483</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen C., Caga J., Mahoney C.J., Kiernan M.C., Huynh W. Behavioural Changes Predict Poorer Survival in Amyotrophic Lateral Sclerosis. Brain Cogn. 2021;150:105710. doi: 10.1016/j.bandc.2021.105710.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bandc.2021.105710</ArticleId><ArticleId IdType="pubmed">33725515</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Eijk R.P.A., Jones A.R., Sproviero W., Shatunov A., Shaw P.J., Leigh P.N., Young C.A., Shaw C.E., Mora G., Mandrioli J., et al. Meta-Analysis of Pharmacogenetic Interactions in Amyotrophic Lateral Sclerosis Clinical Trials. Neurology. 2017;89:1915&#x2013;1922. doi: 10.1212/WNL.0000000000004606.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000004606</ArticleId><ArticleId IdType="pmc">PMC5664299</ArticleId><ArticleId IdType="pubmed">28978660</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>